Annual Report 2019

CONSOLIDATEDSTATEMENT OF PROFIT OR LOSSANDOTHER COMPREHENSIVE INCOME For the year ended 31 December 2019 41 The United Laboratories International Holdings Limited Annual Report 2019 2019 2018 NOTES RMB’000 RMB’000 Revenue 5 8,392,600 7,510,586 Cost of sales (4,771,336) (4,458,446) Gross profit 3,621,264 3,052,140 Other income 6 123,059 118,925 Other gains and losses, net 7a (1,773) (121,133) Selling and distribution expenses (1,477,637) (1,186,051) Administrative expenses (740,653) (646,830) Other expenses 7b (386,829) (309,922) Impairment losses under expected credit loss model, net of reversal 9 (7,655) 2,106 Gain on disposal of a subsidiary 10 200,445 – Loss on fair value change on investment properties 19 (97,614) (94,873) (Loss) gain on fair value change of embedded derivative components of convertible bonds 32 (110,117) 226,414 Finance costs 8 (280,838) (246,897) Profit before taxation 841,652 793,879 Tax expense 11 (199,888) (110,951) Profit for the year attributable to owners of the Company 12 641,764 682,928 Other comprehensive (expense) income Item that may be reclassified subsequently to profit or loss: Exchange differences arising on translation of a foreign operation (1,971) 615 Total comprehensive income for the year attributable to owners of the Company 639,793 683,543 Earnings per share (RMB cents) 16 – Basic 39.14 41.80 – Diluted 39.14 32.27